According to a nationwide study conducted by the University of Michigan in the United States, nicotine e-cigarettes will be the most commonly used drug among teenagers in 2022.
Among 8th grade students within the last 30 days of 2022, 7% reported using nicotine, with 6% using nicotine in combination with alcohol and 5% using nicotine in combination with marijuana. In the 10th grade, 14% of students reported using nicotine within the last 30 days, while alcohol use was reported at 13.6% and marijuana use at 12%.
Among 12th grade students, the prevalence of nicotine e-cigarette use in the past 30 days is close to 21%, with alcohol use below 28%, but similar to marijuana at 20%.
A group of professors from the Institute for Social Research at the University of Michigan conduct an annual study called "Monitoring the Future," which assesses the drug use of nationally representative samples of 8th, 10th, and 12th grade teenagers since 1991 and 1975, respectively. The study is funded by the National Institute on Drug Abuse, part of the National Institutes of Health, and evaluates teenagers' use of dozens of drugs.
Richard Miech, chief researcher and professor of social research at the institute, stated that many people are unaware of how common nicotine e-cigarettes are among teenagers. Usage has rapidly increased in both 2018 and 2019 and has persisted since then. The epidemic of teenage e-cigarette use is becoming a local health crisis.
Miech stated that nicotine is highly addictive, and introducing it to the brain during puberty can impact development and prepare for future drug use. While electronic cigarettes may potentially assist adults in quitting smoking, exposing young brains to nicotine can lead to a lasting physical addiction. Furthermore, emerging evidence suggests that electronic cigarettes may carry their own health risks, such as damage to blood vessels.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
